Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer. [electronic resource]
Producer: 20170615Description: e0165385 p. digitalISSN:- 1932-6203
- Adaptor Proteins, Signal Transducing -- genetics
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Nucleus -- drug effects
- Cisplatin -- pharmacology
- Cohort Studies
- Female
- G2 Phase Cell Cycle Checkpoints -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- M Phase Cell Cycle Checkpoints -- drug effects
- Neoplasm Grading
- Neoplasm Staging
- Ovarian Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.